Skip To Main Content
Shamit K. Dutta on Muck Rack

Shamit K. Dutta

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shamit K.

Contact Shamit K., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme

|
By Ramcharan Singh Angom, Hari Krishnareddy Rachamala, Vijay Sagar Madamsetty, Paola Suarez-Meade, Tanmay A. Kulkarni, Shamit K. Dutta, Enfeng Wang, Santanu Bhattacharya, Krishnendu Pal, Alfredo Quinones-Hinojosa, Debabrata Mukhopadhyay, Beatriz I. Fernandez-Gil, Raegan M. Weil
| Nature Verified
Abstract Glioblastoma (GBM) is the most common high-grade primary malignant brain tumor, characterized by a notably poor prognosis. Current treatments for GBM have shown limited effectiveness in improving patient survival, highlighting the urgent need for effective therapeutic strategies. Combination therapy offers significant potential in overcoming resistance by targeting multiple signaling pathways; however, it often comes with increased toxicity compared to monotherapy.
Open in Who Shared Issue with article?

DNA-SWCNT Biosensors allow real-time monitoring of therapeutic responses in Pancreatic Ductal Adenocarcinoma

|
By Santanu Bhattacharya, Xun Gong, Enfeng Wang, Shamit K. Dutta
| cancerres.aacrjournals.org
Research Article Santanu Bhattacharya, Xun Gong, Enfeng Wang, Shamit K. Dutta, Joseph R Caplette, Manki Son, Freddy T Nguyen, Michael S. Strano and Debabrata Mukhopadhyay DOI: 10.1158/0008-5472.CAN-18-3337 Abstract Pancreatic ductal adenocarcinoma (PDAC) is a highly desmoplastic cancer with limited treatment options. There is an urgent need for tools that monitor therapeutic responses in real-time.
Open in Who Shared Issue with article?
See all 2 articles